Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Arthurian Life Sciences was formed to manage the £100m Wales Life Sciences Investment Fund (WLSIF), backed by £50m from the Welsh Government. The fund was later managed by Arix Bioscience after acquisition and was wound up by 2023, meeting job creation objectives despite a negative overall return.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Welsh Arthurian Life Sciences Fund.